Cargando…

Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials

Heart failure (HF) is a global pandemic with increasing prevalence and mortality rates annually. Its main cause is myocardial infarction (MI), followed by rapid cardiac remodeling. Several clinical studies have shown that probiotics can improve the quality of life and reduce cardiovascular risk fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Taslim, Nurpudji Astuti, Yusuf, Muhammad, Ambari, Ade Meidian, Del Rosario Puling, Imke Maria, Ibrahim, Filzatuz Zahro, Hardinsyah, Hardinsyah, Kurniawan, Rudy, Gunawan, William Ben, Mayulu, Nelly, Joseph, Victor F. F., Sabrina, Nindy, Rizal, Mochammad, Tallei, Trina Ekawati, Kim, Bonglee, Tsopmo, Apollinaire, Nurkolis, Fahrul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393865/
https://www.ncbi.nlm.nih.gov/pubmed/37349622
http://dx.doi.org/10.1007/s12602-023-10105-2
_version_ 1785083239283556352
author Taslim, Nurpudji Astuti
Yusuf, Muhammad
Ambari, Ade Meidian
Del Rosario Puling, Imke Maria
Ibrahim, Filzatuz Zahro
Hardinsyah, Hardinsyah
Kurniawan, Rudy
Gunawan, William Ben
Mayulu, Nelly
Joseph, Victor F. F.
Sabrina, Nindy
Rizal, Mochammad
Tallei, Trina Ekawati
Kim, Bonglee
Tsopmo, Apollinaire
Nurkolis, Fahrul
author_facet Taslim, Nurpudji Astuti
Yusuf, Muhammad
Ambari, Ade Meidian
Del Rosario Puling, Imke Maria
Ibrahim, Filzatuz Zahro
Hardinsyah, Hardinsyah
Kurniawan, Rudy
Gunawan, William Ben
Mayulu, Nelly
Joseph, Victor F. F.
Sabrina, Nindy
Rizal, Mochammad
Tallei, Trina Ekawati
Kim, Bonglee
Tsopmo, Apollinaire
Nurkolis, Fahrul
author_sort Taslim, Nurpudji Astuti
collection PubMed
description Heart failure (HF) is a global pandemic with increasing prevalence and mortality rates annually. Its main cause is myocardial infarction (MI), followed by rapid cardiac remodeling. Several clinical studies have shown that probiotics can improve the quality of life and reduce cardiovascular risk factors. This systematic review and meta-analysis aimed to investigate the effectiveness of probiotics in preventing HF caused by a MI according to a prospectively registered protocol (PROSPERO: CRD42023388870). Four independent evaluators independently extracted the data using predefined extraction forms and evaluated the eligibility and accuracy of the studies. A total of six studies consisting of 366 participants were included in the systematic review. Probiotics are not significant in intervening left ventricular ejection fraction (LVEF) and high-sensitivity C-reactive protein (hs-CRP) when compared between the intervention group and the control group due to inadequate studies supporting its efficacy. Among sarcopenia indexes, hand grip strength (HGS) showed robust correlations with the Wnt biomarkers (p < 0.05), improved short physical performance battery (SPPB) scores were also strongly correlated with Dickkopf-related protein (Dkk)-3, followed by Dkk-1, and sterol regulatory element-binding protein 1 (SREBP-1) (p < 0.05). The probiotic group showed improvement in total cholesterol (p = 0.01) and uric acid (p = 0.014) compared to the baseline. Finally, probiotic supplements may be an anti-inflammatory, antioxidant, metabolic, and intestinal microbiota modulator in cardiac remodeling conditions. Probiotics have great potential to attenuate cardiac remodeling in HF or post-MI patients while also enhancing the Wnt signaling pathway which can improve sarcopenia under such conditions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12602-023-10105-2.
format Online
Article
Text
id pubmed-10393865
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-103938652023-08-03 Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials Taslim, Nurpudji Astuti Yusuf, Muhammad Ambari, Ade Meidian Del Rosario Puling, Imke Maria Ibrahim, Filzatuz Zahro Hardinsyah, Hardinsyah Kurniawan, Rudy Gunawan, William Ben Mayulu, Nelly Joseph, Victor F. F. Sabrina, Nindy Rizal, Mochammad Tallei, Trina Ekawati Kim, Bonglee Tsopmo, Apollinaire Nurkolis, Fahrul Probiotics Antimicrob Proteins Research Heart failure (HF) is a global pandemic with increasing prevalence and mortality rates annually. Its main cause is myocardial infarction (MI), followed by rapid cardiac remodeling. Several clinical studies have shown that probiotics can improve the quality of life and reduce cardiovascular risk factors. This systematic review and meta-analysis aimed to investigate the effectiveness of probiotics in preventing HF caused by a MI according to a prospectively registered protocol (PROSPERO: CRD42023388870). Four independent evaluators independently extracted the data using predefined extraction forms and evaluated the eligibility and accuracy of the studies. A total of six studies consisting of 366 participants were included in the systematic review. Probiotics are not significant in intervening left ventricular ejection fraction (LVEF) and high-sensitivity C-reactive protein (hs-CRP) when compared between the intervention group and the control group due to inadequate studies supporting its efficacy. Among sarcopenia indexes, hand grip strength (HGS) showed robust correlations with the Wnt biomarkers (p < 0.05), improved short physical performance battery (SPPB) scores were also strongly correlated with Dickkopf-related protein (Dkk)-3, followed by Dkk-1, and sterol regulatory element-binding protein 1 (SREBP-1) (p < 0.05). The probiotic group showed improvement in total cholesterol (p = 0.01) and uric acid (p = 0.014) compared to the baseline. Finally, probiotic supplements may be an anti-inflammatory, antioxidant, metabolic, and intestinal microbiota modulator in cardiac remodeling conditions. Probiotics have great potential to attenuate cardiac remodeling in HF or post-MI patients while also enhancing the Wnt signaling pathway which can improve sarcopenia under such conditions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12602-023-10105-2. Springer US 2023-06-22 2023 /pmc/articles/PMC10393865/ /pubmed/37349622 http://dx.doi.org/10.1007/s12602-023-10105-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Taslim, Nurpudji Astuti
Yusuf, Muhammad
Ambari, Ade Meidian
Del Rosario Puling, Imke Maria
Ibrahim, Filzatuz Zahro
Hardinsyah, Hardinsyah
Kurniawan, Rudy
Gunawan, William Ben
Mayulu, Nelly
Joseph, Victor F. F.
Sabrina, Nindy
Rizal, Mochammad
Tallei, Trina Ekawati
Kim, Bonglee
Tsopmo, Apollinaire
Nurkolis, Fahrul
Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials
title Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials
title_full Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials
title_fullStr Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials
title_full_unstemmed Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials
title_short Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials
title_sort anti-inflammatory, antioxidant, metabolic and gut microbiota modulation activities of probiotic in cardiac remodeling condition: evidence from systematic study and meta-analysis of randomized controlled trials
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393865/
https://www.ncbi.nlm.nih.gov/pubmed/37349622
http://dx.doi.org/10.1007/s12602-023-10105-2
work_keys_str_mv AT taslimnurpudjiastuti antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT yusufmuhammad antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT ambariademeidian antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT delrosariopulingimkemaria antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT ibrahimfilzatuzzahro antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT hardinsyahhardinsyah antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT kurniawanrudy antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT gunawanwilliamben antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT mayulunelly antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT josephvictorff antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT sabrinanindy antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT rizalmochammad antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT talleitrinaekawati antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT kimbonglee antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT tsopmoapollinaire antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials
AT nurkolisfahrul antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials